Glaukos Corp

Company Profile

Glaukos Corp had its IPO on 2015-06-25 under the ticker symbol GKOS.

The company operates in the Healthcare sector and Medical Devices industry. Glaukos Corp has a staff strength of 783 employees.

Stock update

Shares of Glaukos Corp opened at $76.22 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $76.22 - $78.95, and closed at $76.81.

This is a +1.11% increase from the previous day's closing price.

A total volume of 503,365 shares were traded at the close of the day’s session.

In the last one week, shares of Glaukos Corp have increased by +2.56%.

Glaukos Corp's Key Ratios

Glaukos Corp has a market cap of $3.70 billion, indicating a price to book ratio of 3.8455 and a price to sales ratio of 7.1193.

In the last 12-months Glaukos Corp’s revenue was $296.79 million with a gross profit of $213.88 million and an EBITDA of $-81652000. The EBITDA ratio measures Glaukos Corp's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Glaukos Corp’s operating margin was -38.55% while its return on assets stood at -7.19% with a return of equity of -24.06%.

In Q2, Glaukos Corp’s quarterly earnings growth was a positive 1896.3% while revenue growth was a positive 10.6%.

Glaukos Corp’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

1.64

Its diluted EPS in the last 12-months stands at $-2.6 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of 1.64. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Glaukos Corp’s profitability.

Glaukos Corp stock is trading at a EV to sales ratio of 7.4781 and a EV to EBITDA ratio of -52.9247. Its price to sales ratio in the trailing 12-months stood at 7.1193.

Glaukos Corp stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$956.74 million

Total Liabilities

$63.89 million

Operating Cash Flow

$25.95 million

Capital Expenditure

$5.77 million

Dividend Payout Ratio

0%

Glaukos Corp ended 2024 with $956.74 million in total assets and $0 in total liabilities. Its intangible assets were valued at $956.74 million while shareholder equity stood at $488.81 million.

Glaukos Corp ended 2024 with $0 in deferred long-term liabilities, $63.89 million in other current liabilities, 48000.00 in common stock, $-531844000.00 in retained earnings and $66.13 million in goodwill. Its cash balance stood at $94.81 million and cash and short-term investments were $303.81 million. The company’s total short-term debt was $0 while long-term debt stood at $282.09 million.

Glaukos Corp’s total current assets stands at $401.26 million while long-term investments were $0 and short-term investments were $209.00 million. Its net receivables were $39.25 million compared to accounts payable of $8.56 million and inventory worth $39.45 million.

In 2024, Glaukos Corp's operating cash flow was $25.95 million while its capital expenditure stood at $5.77 million.

Comparatively, Glaukos Corp paid $0 in dividends in 2024.

Other key metrics

Current Trading Price

$76.81

52-Week High

$80.28

52-Week Low

$40.45

Analyst Target Price

$84.22

Glaukos Corp stock is currently trading at $76.81 per share. It touched a 52-week high of $80.28 and a 52-week low of $80.28. Analysts tracking the stock have a 12-month average target price of $84.22.

Its 50-day moving average was $74.36 and 200-day moving average was $57.23 The short ratio stood at 11.78 indicating a short percent outstanding of 0%.

Around 389% of the company’s stock are held by insiders while 10111.4% are held by institutions.